Loading...

Atwood, Scott

TitleAssistant Professor
InstitutionUniversity of California, Irvine
DepartmentDevelopmental & Cell Biology
Address4238 McGaugh Hall
Zot 2300
CA 92697
Phone(949) 824-4346
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nguyen TTL, Atwood S. Illuminating Alternative Strategies to Treat Targeted Chemotherapy-Resistant Sporadic Basal Cell Carcinoma. J Invest Dermatol. 2018 May; 138(5):1017-1019. PMID: 29681387.
      View in: PubMed
    2. Whitson RJ, Lee A, Urman NM, Mirza A, Yao CY, Brown AS, Li JR, Shankar G, Fry MA, Atwood S, Lee EY, Hollmig ST, Aasi SZ, Sarin KY, Scott MP, Epstein EH, Tang JY, Oro AE. Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat Med. 2018 Mar; 24(3):271-281. PMID: 29400712.
      View in: PubMed
    3. Mirza AN, Fry MA, Urman NM, Atwood S, Roffey J, Ott GR, Chen B, Lee A, Brown AS, Aasi SZ, Hollmig T, Ator MA, Dorsey BD, Ruggeri BR, Zificsak CA, Sirota M, Tang JY, Butte A, Epstein E, Sarin KY, Oro AE. Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment. JCI Insight. 2017 Nov 02; 2(21). PMID: 29093271.
      View in: PubMed
    4. Nguyen K, Fazio M, Kubota M, Nainar S, Feng C, Li X, Atwood S, Bredy TW, Spitale RC. Cell-Selective Bioorthogonal Metabolic Labeling of RNA. J Am Chem Soc. 2017 02 15; 139(6):2148-2151. PMID: 28139910.
      View in: PubMed
    5. Drummond ML, Atwood S. sm"FISH"ing for Hedgehog. J Invest Dermatol. 2017 Jan; 137(1):13-15. PMID: 28010757.
      View in: PubMed
    6. Urman NM, Mirza A, Atwood S, Whitson RJ, Sarin KY, Tang JY, Oro AE. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions. PLoS One. 2016; 11(12):e0168031. PMID: 28030567.
      View in: PubMed
    7. Ally MS, Ransohoff K, Sarin K, Atwood S, Rezaee M, Bailey-Healy I, Kim J, Beachy PA, Chang AL, Oro A, Tang JY, Colevas AD. Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. JAMA Dermatol. 2016 Apr; 152(4):452-6. PMID: 26765315; PMCID: PMC4833646.
    8. Jaju PD, Nguyen CB, Mah AM, Atwood S, Li J, Zia A, Chang ALS, Oro AE, Tang JY, Lee CS, Sarin KY. Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. J Invest Dermatol. 2015 Dec; 135(12):3197-3200. PMID: 26348826; PMCID: PMC4747638.
    9. Zhao X, Ponomaryov T, Ornell KJ, Zhou P, Dabral SK, Pak E, Li W, Atwood S, Whitson RJ, Chang AL, Li J, Oro AE, Chan JA, Kelleher JF, Segal RA. RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors. Cancer Res. 2015 Sep 01; 75(17):3623-35. PMID: 26130651; PMCID: PMC4558230.
    10. Atwood S, Sarin KY, Li JR, Yao CY, Urman NM, Chang ALS, Tang JY, Oro AE. Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. J Invest Dermatol. 2015 Aug; 135(8):2138-2141. PMID: 25801792; PMCID: PMC4504757.
    11. Atwood S, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, Ally MS, Kim J, Yao C, Chang AL, Oro AE, Tang JY. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 2015 Mar 09; 27(3):342-53. PMID: 25759020; PMCID: PMC4357167.
    12. Atwood S, Whitson RJ, Oro AE. Advanced treatment for basal cell carcinomas. Cold Spring Harb Perspect Med. 2014 Jul 01; 4(7):a013581. PMID: 24985127; PMCID: PMC4066644.
    13. Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, Ponnuswami A, Monje M, Atwood S, Whitson RJ, Mitra S, Cheshier SH, Qi J, Beroukhim R, Tang JY, Wechsler-Reya R, Oro AE, Link BA, Bradner JE, Cho YJ. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nat Med. 2014 Jul; 20(7):732-40. PMID: 24973920.
      View in: PubMed
    14. Atwood S, Oro AE. "Atypical" regulation of Hedgehog-dependent cancers. Cancer Cell. 2014 Feb 10; 25(2):133-4. PMID: 24525228; PMCID: PMC4024826.
    15. Chang ALS, Atzmon G, Bergman A, Brugmann S, Atwood S, Chang HY, Barzilai N. Identification of genes promoting skin youthfulness by genome-wide association study. J Invest Dermatol. 2014 Mar; 134(3):651-657. PMID: 24037343; PMCID: PMC3923276.
    16. Atwood S, Whitson RJ, Oro AE. "Patch"ing up our tumor signaling knowledge. J Invest Dermatol. 2013 May; 133(5):1131-3. PMID: 23594533; PMCID: PMC4006018.
    17. Chang AL, Atwood S, Tartar DM, Oro AE. Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome. JAMA Dermatol. 2013 May; 149(5):639-41. PMID: 23677114; PMCID: PMC4006072.
    18. Atwood S, Li M, Lee A, Tang JY, Oro AE. GLI activation by atypical protein kinase C ?/? regulates the growth of basal cell carcinomas. Nature. 2013 Feb 28; 494(7438):484-8. PMID: 23446420; PMCID: PMC3761364.
    19. Woo WM, Atwood S, Zhen HH, Oro AE. Rapid genetic analysis of epithelial-mesenchymal signaling during hair regeneration. J Vis Exp. 2013 Feb 28; (72):e4344. PMID: 23486463; PMCID: PMC3622109.
    20. Atwood S, Chang AL, Oro AE. Hedgehog pathway inhibition and the race against tumor evolution. J Cell Biol. 2012 Oct 15; 199(2):193-7. PMID: 23071148; PMCID: PMC3471227.
    21. Graybill C, Wee B, Atwood S, Prehoda KE. Partitioning-defective protein 6 (Par-6) activates atypical protein kinase C (aPKC) by pseudosubstrate displacement. J Biol Chem. 2012 Jun 15; 287(25):21003-11. PMID: 22544755; PMCID: PMC3375524.
    22. Bershteyn M, Atwood S, Woo WM, Li M, Oro AE. MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Dev Cell. 2010 Aug 17; 19(2):270-83. PMID: 20708589; PMCID: PMC3108505.
    23. Atwood S, Prehoda KE. aPKC phosphorylates Miranda to polarize fate determinants during neuroblast asymmetric cell division. Curr Biol. 2009 May 12; 19(9):723-9. PMID: 19375318; PMCID: PMC2689075.
    24. Atwood S, Chabu C, Penkert RR, Doe CQ, Prehoda KE. Cdc42 acts downstream of Bazooka to regulate neuroblast polarity through Par-6 aPKC. J Cell Sci. 2007 Sep 15; 120(Pt 18):3200-6. PMID: 17726059; PMCID: PMC1988841.
    Scott's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _